110 related articles for article (PubMed ID: 9575584)
1. [The effect of salben on the rheological properties of the bronchial secretion].
Marinin VF; Kakhnovskiĭ IM; Sorokina LA; Smirnova ZV; Arkhipova SV
Ter Arkh; 1998; 70(3):29-32. PubMed ID: 9575584
[TBL] [Abstract][Full Text] [Related]
2. [Cardiac monitoring in bronchial asthma patients taking salben].
Kakhnovskiĭ IM; Marinin VF; Sorokina LA; Markova ZS
Ter Arkh; 1996; 68(3):50-2. PubMed ID: 8744105
[No Abstract] [Full Text] [Related]
3. [Effects of combined therapy with domestic inhalational anti-asthmatic drugs on oxidant status of patients with bronchial asthma].
Kolpakova AF
Ter Arkh; 2007; 79(3):41-4. PubMed ID: 17526195
[TBL] [Abstract][Full Text] [Related]
4. Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate.
Stigliani M; Manniello MD; Zegarra-Moran O; Galietta L; Minicucci L; Casciaro R; Garofalo E; Incarnato L; Aquino RP; Del Gaudio P; Russo P
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):337-45. PubMed ID: 26741302
[TBL] [Abstract][Full Text] [Related]
5. [Effects of oral tulobuterol on bronchial obstruction in asthmatic patients].
Vergeret J; Taytard A
Therapie; 1988; 43(1):21-4. PubMed ID: 3358248
[No Abstract] [Full Text] [Related]
6. Is the tolerance to the bronchoprotective effect of salmeterol clinically relevant?
Nathan RA
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):1-3; discussion 4. PubMed ID: 9475559
[No Abstract] [Full Text] [Related]
7. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
8. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
9. Acute effect of an inhaled glucocorticosteroid on albuterol-induced bronchodilation in patients with moderately severe asthma.
Mendes ES; Cadet L; Arana J; Wanner A
Chest; 2015 Apr; 147(4):1037-1042. PubMed ID: 25611803
[TBL] [Abstract][Full Text] [Related]
10. [Possibilities and limitations of using inhaled sympathomimetics in patients with bronchial asthma in older age groups].
Gembitskiĭ EV; Sinopal'nikov AI; Alekseev VG
Ter Arkh; 1988; 60(1):131-4. PubMed ID: 3283988
[TBL] [Abstract][Full Text] [Related]
11. Familial aggregation of bronchodilator response: a community-based study.
Niu T; Rogus JJ; Chen C; Wang B; Yang J; Fang Z; Weiss ST; Xu X
Am J Respir Crit Care Med; 2000 Nov; 162(5):1833-7. PubMed ID: 11069822
[TBL] [Abstract][Full Text] [Related]
12. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
Kamin W; Schwabe A; Krämer I
J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
[TBL] [Abstract][Full Text] [Related]
14. Effects of drugs on mucus glycoproteins and water in bronchial secretion.
Medici TC; Radielovic P
J Int Med Res; 1979; 7(5):434-42. PubMed ID: 40841
[No Abstract] [Full Text] [Related]
15. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
16. Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.
Raphael G; Taveras H; Iverson H; O'Brien C; Miller D
J Asthma; 2016; 53(2):187-93. PubMed ID: 26369589
[TBL] [Abstract][Full Text] [Related]
17. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
[TBL] [Abstract][Full Text] [Related]
18. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma].
Tsukioka K; Nakamata M; Kondo A; Hashimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948
[TBL] [Abstract][Full Text] [Related]
19. [The use of expectorant agents].
Galsanov Shch B
Sov Med; 1987; (12):100-5. PubMed ID: 3328304
[No Abstract] [Full Text] [Related]
20. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma.
Szczeklik A; Mastalerz L; Nizankowska E; Cmiel A
Am J Respir Crit Care Med; 1996 Feb; 153(2):567-71. PubMed ID: 8564099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
